Neurogenic Mechanisms in Burning Mouth Syndrome (BMS17)
Neurogenic Mechanisms in Burning Mouth Syndrome (BMS17) This study is currently recruiting participants. Verified by University of Copenhagen, April 2009 First Received: April 2, 2009 No Change
An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome
OBJECTIVE: The objective of this study was to evaluate the effectiveness and tolerability of paroxetine in patients with burning mouth syndrome (BMS). DESIGN: In a 12-week open-label, noncomparative,
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder This study is currently recruiting participants. Verified by Charite University, Berlin, Germany, May 2008 Sponsors and Collaborators:
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder This study is currently recruiting participants. Verified by Charite University, Berlin, Germany, March 2009 First Received: July 19, 2007
Burning mouth disorder (BMD) and taste: a hypothesis
BACKGROUND: Burning mouth disorder (BMD) is a burning or stinging sensation affecting the oral mucosa, lips, and/or tongue, in the absence of clinically visible mucosal lesions. There is a strong fema
Burning mouth syndrome
Burning mouth syndrome (BMS) is characterized by oral burning or similar pain in the absence of detectable oral mucosa changes. This condition is more common among middle-aged and elderly women. Altho
Burning Mouth Syndrome
Burning mouth syndrome John Buchanan and Joanna Zakrzewska Definition Burning mouth syndrome is an idiopathic burning discomfort or pain affecting people with clinically normal oral mucosa, in
Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study
Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study To study the efficacy of alpha lipoic acid (ALA) in a group of patients with burning mouth syndrome (BMS
Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain This study is currently recruiting participants. Verified by University of California, San Francisc
Electroconvulsive therapy for burning mouth syndrome
Objective: Burning mouth syndrome (BMS) is an orofacial pain disorder characterized by a chronic, idiopathic burning sensation of the oral mucosa that mostly affects middle-aged women. Although both p
Interventions for the treatment of burning mouth syndrome
Interventions for the treatment of burning mouth syndrome Zakrzewska JM, Forssell H, Glenny A-M Bookmark this: connotea Bibsonomy del.icio.us CiteULike Newsvine more ... loading... please wait
Quality of life in patients with burning mouth syndrome
OBJECTIVE: To study the quality of life in patients with burning mouth syndrome (BMS), our primary aim was to compare BMS patients with healthy controls and the secondary aim was to compare subgroups